Overview

Dexmedetomidine on Prevention of Side Effects of Hemabate

Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Hemabate is often used for gynecological patients. Hemabate is associated with many side effects, including a burning sensation in the stomach, nausea, vomiting, diarrhea etc. It is reported that dexmedetomidine reduce gastrointestinal reaction during perioperative period. We design this clinical trial to find if dexmedetomidine can prevent the side effects of hemabate in Cesarean Section patients.
Phase:
Phase 4
Details
Lead Sponsor:
Jin Ni
Treatments:
Carboprost
Carboprost tromethamine
Dexmedetomidine